Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years

1 week ago

Anavex's blarcamesine shows sustained cognitive and functional benefit in early Alzheimer's patients after four years of continuous treatment.This …